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A B S T R A C T
African swine fever (ASF) is a devastating disease for which there is no vaccine. The ASF virus (ASFV) can infect
dendritic cell (DC), but despite the critical role these cells play in induction of adaptive immunity, few studies
investigated their response to ASFV infection. We characterized the in vitro interactions of porcine monocyte-
derived DCs (moDC) with a virulent (22653/14), a low virulent (NH/P68) and an avirulent (BA71V) ASFV
strain. At a high multiplicity of infection (MOI= 1), all three strains infected immature moDC. Maturation of
moDC, with IFN-α/TNF-α, increased susceptibility to infection with 22653/14 and other virulent strains, but
reduced susceptibility to NH/P68 and BA71V. The reduced moDC susceptibility to BA71V/NH/P68 was IFN-α
mediated, whereas increased susceptibility to 22653/14 was induced by TNF-α. Using an MOI of 0.01, we
observed that BA71V replicated less eﬃciently in moDC compared to the other isolates and we detected in-
creased replication of NH/P68 compared to 22653/14. We observed that BA71V and NH/P68, but not 22653/
14, downregulated expression of MHC class I on infected cells. All three strains decreased CD16 expression on
moDC, whereas ASFV infection resulted in CD80/86 down-regulation and MHC class II DR up-regulation on
mature moDC. None of the tested strains induced a strong cytokine response to ASFV and only modest IL-1α was
released after BA71V infection. Overall our results revealed diﬀerences between strains and suggest that ASFV
has evolved mechanisms to replicate covertly in inﬂammatory DC, which likely impairs the induction of an
eﬀective immune response.
1. Introduction
African swine fever (ASF) is a contagious and often fatal disease of
domestic and wild pigs, for which there is no vaccine or treatment
available (Sanchez-Vizcaino et al., 2006). It is currently present in
many sub-Saharan African countries, Russian Federation, Trans-Cau-
casus, East and Central Europe and Sardinia (OIE, WAHIS interface).
The aetiological agent is the African swine fever virus (ASFV), a large,
enveloped double-stranded DNA virus, which is the only member of the
Asfarviridae family (Dixon et al., 2005).
ASFV infects immune cells of the myeloid lineage. While monocytes
and macrophages are considered the primary target cells (Sánchez-
Cordón et al., 2008), ASFV can infect dendritic cells (DC) (Gregg et al.,
1995a). DC are the most potent antigen-presenting cells responsible for
the induction of adaptive immune responses against pathogens
(Banchereau and Steinman, 1998). After detection and antigen uptake,
DCs migrate into secondary lymphoid tissues to present the processed
antigen to T lymphocytes. A maturation step, often achieved by the
engagement of pattern recognition receptors with pathogen-associated
molecular patterns, is essential for DC to execute their role in an eﬃ-
cient manner (McCullough and Summerﬁeld, 2009). DC can be broadly
divided into two subpopulations: conventional DC (cDC), whose main
function is antigen-presentation, and plasmacytoid DC (pDC), specia-
lized in rapidly secreting large amounts of IFN-α (McCullough and
Summerﬁeld, 2009). Due to the low frequency of DC in the circulation
and lymphoid organs, myeloid DC can be generated in vitro from
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monocytes, through incubation with GM-CSF and IL-4 (Carrasco et al.,
2001). These monocyte-derived DC (moDC) represent a third popula-
tion of DC, termed inﬂammatory DC, which are thought to diﬀerentiate
in vivo during infection and inﬂammation (Hespel and Moser, 2012).
Porcine moDC present a CD1+CD14+/−CD16+CD80/
86+CD172+MHC-I+MHC-II+CD4-CD3-CD8- phenotype, possess a
strong T-cell stimulatory capacity, and are in an immature state
(Carrasco et al., 2001, McCullough and Summerﬁeld, 2009). Stimula-
tion of moDC with recombinant IFN-α and TNF-α induces phenotypic
maturation, with increased MHC II and CD80/86 surface expression
(Carrasco et al., 2004).
To date, few studies have analysed the interaction of ASFV with DC
and none have assessed moDC/ASFV interaction. Previous studies have
demonstrated that ASFV can infect dermal DC, resulting in interference
with subsequent infection with foot-and-mouth disease virus (Gregg
et al., 1995a). It has been observed that virulent ASFV is able to infect
cDC in vivo leading to a reduction in the number of interdigitating cDC
in mandibular lymph nodes from three days post-infection, which might
limit the development of a protective immune response (Gregg et al.,
1995b). A recent study reported that in vitro infection of enriched blood
DC with ASFV induced high levels of type I interferon (IFN), suggesting
that ASFV-infected pDC could be a potential source of type I IFN in
animals undergoing acute ASF (Golding et al., 2016). Infection of DC
with ASFV is likely to play a critical role in modulating the immune
response. Diﬀerences might exist also between ASFV strains varying in
virulence, since we and others have demonstrated that macrophage
cytokine responses diﬀer between attenuated and virulent strains (Gil
et al., 2008, Reis et al., 2016, Franzoni et al., 2017).
Considering the central role of DC in initiating a protective immune
defence against pathogens, we hypothesized that moDC would respond
diﬀerently to ASFV strains of spanning the spectrum of virulence, with
more pathogenic strains possessing mechanisms to modulate moDC
responses in order to evade immune defences. To address these issues,
we conducted a thorough in vitro analysis of the interaction of immature
and mature moDC with a virulent (22653/14), a low virulent (NH/P68)
and an avirulent (BA71V) ASFV strain.
2. Materials and methods
2.1. Animals
Healthy ASFV-naïve cross-bred pigs (Sus scrofa), 4–12 month old,
were used in the study. The ASFV negative status of the animals was
conﬁrmed by real-time PCR (King et al., 2003), a commercial antibody
ELISA test (Ingenasa, Madrid, Spain) and an immunoblotting test (OIE,
2012). The animals were housed at the Experiment Station of IZS della
Sardegna (Sassari, Italy) and animal housing and handling procedures
were performed in accordance with the local ethics committee, in
agreement with the guide of use of laboratory animals issued by the
Italian Ministry of Health. Heparinized blood was collected by puncture
of the cranial vena cava, using a 50mL syringe containing sodium he-
parin connected to a 2.0× 45mm 14-gauge needle (Delta Med, Man-
tova, Italy).
2.2. Viruses
The tissue-culture adapted avirulent ASFV BA71V strain (kindly
provided by the EU ASF Reference Laboratory CISA-INIA, Madrid,
Spain) was propagated in vitro by inoculation of sub-conﬂuent mono-
layers of Vero cells; virus titres were obtained by serial dilution of the
virus suspension on Vero cells in 96-well plates, followed by observa-
tion for cytopathic eﬀect and crystal violet staining to identify infection
rates, as previously described (Carrascosa et al., 2011). Mock-virus
supernatants were prepared in identical manner from uninfected Vero
cell cultures (‘Mock Vero’). The virulent ASFV ﬁeld strains 22653/14,
28784/16 (Exotic Disease Laboratory ASF Virus Archive, IZS of
Sardinia, Sassari, Italy), Italy/83 (kindly provided by Dr Gian Mario De
Mia, Italian ASF Reference Laboratory, CEREP, Italy), Arm07 and
Ken06.Bus (kindly provided by the EU ASF Reference Laboratory CISA-
INIA, Madrid, Spain), and the low virulent NH/P68 (kindly provided by
the EU ASF Reference Laboratory CISA-INIA, Madrid, Spain) were
propagated in vitro by inoculation of sub-conﬂuent monolayers of por-
cine monocytes/macrophages, as previously described (Malmquist and
Hay, 1960). Titres of 22653/14, 28784/16, Italy/83, Arm07,
Ken06.Bus ASFV strains were obtained by serial dilution of the virus
suspension on monocyte/macrophages in 96-well plates followed by
haemadsorption (Malmquist and Hay, 1960). Viral titres of 22653/14
and the non-haemoadsorbing NH/P68 were obtained by serial dilution
of the virus suspension on monocyte/macrophages in 96-well plates
followed by immunoﬂuorescence staining (OIE, 2012). In brief,
medium was removed from each well, cell monolayers washed with PBS
and ﬁxed by addition of 30% acetone-70% methanol for 15min. After
two washes with PBS, cells were incubated 1 h at 37 °C 5% CO2 with
FITC-conjugated anti-ASFV polyclonal antibody (kindly provided by Dr
Gian Mario De Mia, Italian ASF Reference Laboratory, CEREP, Italy)
diluted 1:200 in PBS and then washed twice with PBS before viewing
under a ﬂuorescent microscope (OIE, 2012). Viral titres were de-
termined using the Spearman–Kärber formula. Mock-virus supernatants
were prepared in identical manner from uninfected monocyte/macro-
phage cultures (‘Mock macro’). Partial p72 gene characterization de-
monstrated that the Sardinian ﬁeld strains 28784/16 and Italy/83 be-
longed to genotype I (Bastos et al., 2003). Additional genotype I strains
tested were BA71V, NH/P68, 22653/14 (Gallardo et al., 2009, Franzoni
et al., 2017), whereas Arm07 and Ken06.Bus belong to genotype II and
IX, respectively (Gallardo et al., 2014, Gallardo et al., 2009).
2.3. Generation of porcine monocyte-derived dendritic cells and activation
Porcine leukocytes were obtained from heparinized blood, as pre-
viously described with slight modiﬁcations (OIE, 2012). In brief, blood
was centrifuged at 700 g for 30min at 4 °C with no breaks, buﬀy coat
was collected, washed ﬁrst in red blood cell lysis buﬀer (distilled water
with 0.5mM Na EDTA, 310mM NH4Cl, 24mM NaHCO3) and then in
PBS. Leukocytes were then re-suspended in RPMI-1640 supplemented
with 10% fetal bovine serum (FBS) and 100 U/ml penicillin and 100 μg/
ml streptomycin (monocyte medium). Monocytes were enriched using
ﬂasks pre-incubated with autologous plasma, as previously described
(Franzoni et al., 2017). Monocytes were detached by placing ﬂasks on
ice for 1 h, centrifuged, counted and viability was assessed using a
Countess Automated Cell Counter (Thermo Fisher Scientiﬁc). Cells were
re-suspended in monocyte medium and were seeded in a 12 well plates
(Greiner CELLSTAR, Sigma) (5×105 live cells/well, 1.5 ml/well).
To diﬀerentiate monocytes into dendritic cells (moDC), cells were
cultured for 4 days at 37 °C 5% CO2 in monocyte medium supplemented
with 20 ng/ml of recombinant porcine GM-CSF and 50 ng/ml of re-
combinant porcine IL-4 (both R&D Systems, Minneapolis, USA) (Kyrova
et al., 2014). At day 4 media was replaced and cells were cultured at
37 °C 5% CO2 for further 2 days in monocyte medium supplemented
with IL-4/GM-CSF alone or with 1000 U/ml recombinant porcine IFN-α
(PBL Assay Science, Piscataway, NJ, USA) and 10 ng/ml recombinant
porcine TNF-α (R&D System) to induce maturation (Carrasco et al.,
2004). In deﬁned experiments, cells were activated using IFN-α or TNF-
α alone.
2.4. Confocal microscopy
Diﬀerentiation of monocytes into moDC were observed by confocal
microscopy, as previously described (Kyrova et al., 2014, Franzoni
et al., 2017). Monocytes were cultured on two-well chamber slides
(Thermo Fisher Scientiﬁc) and were stained immediately or diﬀer-
entiated in moDC and then left untreated or matured with IFN-α/TNF-
α. Cells were ﬁxed with 4% paraformaldehyde and labelled with
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Hoechst for nuclear staining and Alexa Fluor 488-conjugated phalloidin
(Invitrogen) to visualize actin cytoskeleton. Microscopy was performed
using a Leica SP5 Confocal Microscope (Leica Microsystem) equipped
with a 40X Plan-Apo 1.25 NA oil immersion objective. Images were
acquired on a format of 1024× 1024 pixel, with a line average of 2 and
scan speed of 100 Hz. Images were processed with LAS AF Lite software
(Leica Microsystem) for contrast and brightness adjustments. Manip-
ulations did not change the data content.
2.5. ASFV infection of monocytes/dendritic cells and growth curves
Culture medium from monocytes and moDC cultures were removed
and replaced with a multiplicity of infection (MOI) of 1 of ASFV, diluted
in fresh monocyte medium free of cytokines. To evaluate ASFV growth
kinetics in moDC, cells were instead infected at MOI 0.01 with the
virulent 22653/14, low virulent NH/P68 or avirulent BA71V ASFV
strains. Mock-infected controls were included in each experiment. After
90min of incubation at 37 °C 5% CO2 the virus inoculum was removed,
cells were washed with un-supplemented RPMI-1640 medium and fresh
monocyte medium was added to the wells. Cells were incubated at 37 °C
5% CO2 and harvested after 20 h post-infection (pi). To evaluate growth
kinetics, culture supernatants were instead collected at 0, 24, 48, 72 h
pi. Viral infection was assessed by intracytoplasmic p72 expression
using ﬂow cytometry and culture supernatants were collected to eval-
uate viral titres, viral genome copies or cytokine release in response to
ASFV infection. Supernatants were cleared by centrifugation at 2000×g
for 3min and stored at −80 °C until analysed.
2.6. DNA extraction and real-time PCR
Viral DNA was extracted from 0.2ml of cell culture supernatants
using High Pure PCR Template Preparation Kit according to the man-
ufacturer’s protocols (Roche, Mannheim, Germany). ASFV genome co-
pies were assessed by real-time PCR (King et al., 2003), using the
TaqMan Fast Advanced Master Mix (Applied Biosystems), 0.8 μM of
sense and anti-sense primers (5′-CTG CTC ATG GTA TCA ATC TTA TCG
A-3′and 5′-GAT ACC ACA AGA TCR GCC GT-3′), 0.2 μM of TaqMan
probe 5′-[6-carboxy-ﬂuorescein (FAM)]-CCA CGG GAG GAA TAC CAA
CCCAGT G-3′-[6-carboxy-tetramethyl-rhodamine (TAMRA)] in a total
volume of 25 μl containing 5 μl of extracted DNA. The incubation pro-
ﬁle was established as follows: 40 cycles of denaturation at 95 °C for
15 s, annealing at 58 °C for 60 s, after an initial denaturation step at
95 °C for 10min. The plasmid pEX-K4-ASFV-E70p72 (Euroﬁns Geno-
mics, USA) was used as the template to prepare the standard curve for
the real-time PCR assay. This plasmid contains a full length ASFV p72
sequence and the copy number was calculated based on the plasmid and
insert molecular weight. For each experiment, a standard curve was
prepared by serial dilution (10−1−10-7 copy/μl) of pEX-K4-ASFV-
E70p72 template DNA.
2.7. Cytoﬂuorometric analysis of monocytes and derived dendritic cells
Cells were harvested from cultures using ice cold PBS with 2mM
EDTA, centrifuged at 2000×g for 3min, washed in PBS and transferred
to wells of a 96-well round bottom plate. Viability was assessed by
staining the cells with LIVE/DEAD® Fixable Far Red Dead Cell Stain Kit
(Thermo Fisher Scientiﬁc) for 30min at 4 °C and then washed twice
with PBS supplemented with 2% FBS. Staining methods were then
performed as previously described (Franzoni et al., 2017). Monoclonal
antibodies (mAbs) and staining reagents used to detect surface markers
were: MHC class II DR (2E9/13; Bio-Rad Antibodies, Kidlington, United
Kingdom), MHC class I (JM1E3; Bio-Rad Antibodies), human CD152
mouse Ig fusion protein (CD152-muIg)-RPE (Ancell, Bayport, MS, USA),
CD16-RPE (G7, Thermo Scientiﬁc Pierce, Rockford, IL, USA). Staining
with MHC class II DR and MHC class I mAbs was visualized by sub-
sequent staining with RPE-conjugated goat anti-mouse IgG Fc
polyclonal antibody (Thermo Scientiﬁc Pierce). Surface stained cells
were ﬁxed and permeabilized using Leucoperm, according to manu-
facturer’s protocol (Bio-Rad Antibodies). mAbs used to detect in-
tracellular ASFV proteins were: anti-p72-FITC (18BG3, Ingenasa) and
p30-FITC (kindly provided by Dr Gian Mario De Mia, Italian ASF Re-
ference Laboratory, CEREP, Italy). Flow cytometry analysis were per-
formed on a FACSCalibur (BD Biosciences) and at least 5000 live
monocytes/moDC were acquired. Analysis of data was performed using
Cell Quest Pro Software (BD Biosciences), by gating on viable cells
(Live/Dead Fixable Dead Cell Stain negative) in the monocyte/moDC
population, and then assessing the staining for surface markers/ASFV
proteins. Gates for ASFV proteins were set using the mock-infected
controls, whereas surface markers were set using the corresponding
unstained/isotype controls: unconjugated IgG1 and unconjugated and
IgG2b isotype controls (both Bio-Rad Antibodies) for MHC class I and
MHC class II, respectively, mouse PE-IgG1 isotype control for CD16
(ZX3, Thermo Scientiﬁc Pierce), and unstained control for CD80/86.
2.8. Analysis of the cytokine levels in culture supernatants of monocyte
derived dendritic cells to ASFV infection
The simultaneous measurement of IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-
12, IL-18 and TNF-α in culture supernatants were performed using
Porcine Cytokine/Chemokine Magnetic Bead Panel Quantikine assay
(Merck Millipore, Darmstadt, Germany) and a Bioplex MAGPIX
Multiplex Reader (Bio-Rad, Hercules, USA), according to the manu-
facturers’ instructions. The measurement of IFN-β was instead per-
formed using Swine IFN-βDo-it-Yourself ELISA kit (King Fisher Biotech,
St Paul, USA), according to manufacturer’s directions, and absorbance
was read with an Epoch microplate reader (BioTek, Winoosky, USA).
2.9. Data analysis and statistics
Experiments were performed in duplicate (viral titres, qPCR and
multiplex ELISA) or triplicate (ﬂow cytometry and IFN-β ELISA) and
repeated at least three times with diﬀerent blood donor pigs. Data were
presented as means with standard deviations (SD) quoted to indicate
the uncertainty around the estimate of the group mean. Graphical and
statistical analysis was performed using GraphPad Prism 7.02
(GraphPad Software Inc, La Jolla, USA) and Minitab (Minitab Inc.,
Coventry, UK). All data were checked for normality using the Anderson
Darling test and analysed by the non-parametric Mann-Whitney test or
Kruskal-Wallis followed by Dunn’s multiple comparison test.
3. Results
3.1. ASFV strains of diverse virulence infect immature moDC, however,
maturation with IFN-α/TNF-α enhances susceptibility to virulent but not
attenuated strains
Diﬀerentiation of moDC was initially assessed by confocal micro-
scopy; they presented with an elongated phenotype with characteristic
dendrites (Fig. 1A). As expected, monocyte to moDC diﬀerentiation was
accompanied by MHC II DR up-regulation and increase in forward
(FSC) and size (SSC) scatter parameters (data not shown). Susceptibility
of monocytes and moDC to ASFV infection was assessed by quantiﬁ-
cation of cells containing ASFV late protein p72 and viral titres in the
cell culture supernatants. Cells were mock-infected or infected with the
avirulent BA71V, the attenuated NH/P68 or the virulent Sardinian
isolate 22653/14, using an MOI of 1. For all the isolates, immature
moDC were more susceptible to ASFV infection than freshly isolated
monocytes (Fig. 1). Maturation with IFN-α/TNF-α resulted in a reduced
susceptibility to infection with BA71V and to a lesser extent NH/P68. In
contrast, maturation increased susceptibility to the virulent 22653/14
isolate (Fig. 1B). To determine whether this was a strain speciﬁc eﬀect,
we tested additional virulent ASFV isolates: three genotype I (22653/
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Fig. 1. Susceptibility of porcine monocytes, immature and mature moDC to ASFV infection. Diﬀerentiation of monocytes into moDC and their maturation by treatment with IFN-α/TNF-
αwas morphologically assessed by confocal microscopy (original magniﬁcation 40X) (A). Monocytes, immature moDC and mature moDC (moDC+ IFN-α/TNF-α) were infected with the
avirulent BA71V, the low virulent NH/P68 or the virulent 22653/14 strains using an MOI of 1, alongside mock-infected controls (‘mock Vero’ and ‘mock macro’). 20 h pi percentages of
p72+ cells were evaluated using ﬂow cytometry and viral levels in culture supernatants were assessed by titration. The mean data ± SD from four independent experiments utilizing
diﬀerent animals are shown (B). For each condition (BA71V, NH/P68, and 22653/14) values of IFN-α/TNF-α matured moDC were compared to the corresponding immature moDC
condition, using a Mann-Whitney test; ***p < 0.001, **p < 0.01, *p < 0.05.
Fig. 2. Genotype-independent susceptibility of mature moDC to virulent ASFV. Immature moDC and IFN-α/TNF-αmatured moDC (moDC+ IFN-α/TNF-α) were infected with genotype I
(BA71V, NH/P68, 22653/14, 28784/16, Italy/83), genotype II (Arm07) or genotype IX (Ken06) ASFV strains using an MOI of 1, alongside mock-infected controls. 20 h pi percentages of
p72+ cells were evaluated using ﬂow cytometry. The mean data ± SD from three independent experiments utilizing diﬀerent animals are shown. Percentages of p72+ in mature moDC
cultures were normalised to the corresponding immature moDC condition and were compared using a Mann-Whitney test; ***p < 0.001, **p < 0.01, *p < 0.05.
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14, 28784/16, Italy/83), one genotype II (Arm07) and one genotype IX
(Ken06.Bus) isolates. All virulent isolates displayed an increased ca-
pacity to infect mature compared to immature moDC (Fig. 2, Table 1).
We next assessed if treatment of moDC with IFN-α or TNF-α alone was
responsible for the observed reduction/enhancement in susceptibility to
ASFV. As displayed in Fig. 3, activation with IFN-α, but not TNF-α,
decreased BA71V and NH/P68 infection, with statistically signiﬁcant
diﬀerences in the level of the late viral protein p72, and to a lesser
degree for expression of early protein p30 by BA71V. On the contrary,
TNF-α enhanced the proportion of cells expressing p30 and p72 after
22653/14 infection (Fig. 3).
3.2. Both NH/P68 and 22653/14 replicated eﬃciently in moDC, whereas
the avirulent BA71V displayed a poor ability to produce infectious virus in
these cells
Next, the ability of ASFV strains of diverse virulence to replicate in
these cells and to produce infectious virus was analysed. The kinetic
analysis of the infection of immature and mature moDC with ASFV
BA71V, NH/P68 and 22653/14 was performed using an MOI of 0.01.
Replication was measured by assessing both viral titres and viral
genome copies numbers present in cell culture supernatants over-time.
This analysis showed that the low virulence NH/P68 strain replicated
most eﬃciently; 72 h pi almost ten-fold more genome copies and in-
fectious virus particles were detected compared to 22653/14 (Fig. 4).
The avirulent BA71V displayed the lowest ability to replicate in moDC,
with less than 10,000 TCID50 detected 72 h pi (Fig. 4). In accordance
with what we observed with a higher MOI, also using an MOI of 0.01
BA71V and NH/P68 were sensitive to IFN-α pre-treatment moDC, but
for the NH/P68 the diﬀerences were minimal. On the contrary, moDC
maturation resulted in a more eﬃcient 22653/14 replication in these
cells, albeit without statistical signiﬁcance (Fig. 4).
3.3. Assessment of the modulation of functional surface marker expression
on infected moDC revealed down-regulation of MHC class I by attenuated
but not virulent ASFV
Immature and IFN-α/TNF-α matured moDC were infected with
BA71V, NH/P68 and 22653/14 using MOI 1, alongside mock-infected
controls, and 20 h pi the expression of four functional surface markers
was analysed: MHC I, MHC II DR, CD80/86, CD16. Because in some
pigs BA71V infection resulted in less than 10% p72+ mature moDC, it
was deemed unreliable to analyse BA71V infection for that cell subset.
Infection with BA71V and NH/P68, but not with the virulent 22653/14,
resulted in down-regulation of MHC I on infected cells (Fig. 5). The
avirulent BA71V induced up-regulation of MHC class II DR on im-
mature moDC, whereas all the strains up-regulated this marker on
mature moDC, albeit with statistically signiﬁcance only for NH/P68
(Fig. 5). All the strains down-regulated CD16 expression on moDC.
Infection did not alter CD80/86 expression on immature moDC but
decreased its expression on mature moDC (Fig. 5).
3.4. ASFV infection of immature and mature moDC does not induce a strong
cytokine response
Cells were infected with ASFV using MOI 1, alongside mock-infected
controls, and culture supernatants were collected 20 h pi. No statisti-
cally signiﬁcant IFN-β, IL-1β, IL-6, IL-10, IL-12, IL-18, TNF-α responses
were observed from infected moDC cultures, independent of strain or
maturation status. Diﬀerences were observed only in the levels of IL1-
αwith both immature and mature moDC, releasing low levels of IL1-α
in response to BA71V infection compared to mock infected controls
(Fig. 6).
4. Discussion
Immunisation of pigs with attenuated ASFV strains can confer
protection against related virulent viruses (Takamatsu et al., 2013;
Lacasta et al., 2015; Reis et al., 2017). The mechanisms underlying this
protection are still largely unknown and probably involve several ef-
fector mechanisms (Carlson et al., 2016). A better understanding of
how ASFV interacts with the immune system is essential to develop safe
and eﬃcacious vaccines. Despite the important role that DC play in
linking innate and adaptive immunity against pathogens, little is known
about their interaction with ASFV. This study therefore aimed to
characterise the interaction of ASFV with moDC. Since virulent ASFV
isolates may possess mechanisms to impair DC function/activation,
responses to infection with ASFV strains varying in virulence may
diﬀer. Consequently, we analysed the susceptibility and response of
moDC to ASFV strains of diverse virulence: the virulent 22653/14, the
Table 1
Immature moDC and IFN-α/TNF-α matured moDC infected with ASFV strains belonging
to diﬀerent genotype.
ASFV strain Genotype Immature moDC p72+
cells
IFN-α/TNF-α matured moDC
p72+ cells
Mean SD Mean SD
BA71V I 38.58 2.21 12.88 6.00
NH/P68 I 53.66 6.86 42.28 7.49
22653/14 I 44.39 2.14 60.19 3.57
28784/16 I 47.02 11.78 56.63 17.25
Italy/83 I 30.97 1.73 45.21 1.71
Ken06 IX 19.07 3.78 30.63 6.38
Arm07 II 20.26 4.37 24.70 5.37
moDC were infected using an MOI of 1 and after 20 h percentages of p72+ cells were
evaluated.
Mean data and standard deviation (SD) of nine replicates (three technical replicates from
each of three independent experiments using diﬀerent pigs) are shown.
Fig. 3. Expression of early and late ASFV proteins in moDC matured with IFN-α and/or TNF-α. Immature moDC were left untreated or matured with IFN-α and/or TNF-α for 48 h and
then mock-infected or infected with BA71V or NH/P68 or 22653/14. 20 h pi expression of p30 and p72 were assessed by ﬂow cytometry. The mean data ± SD from three independent
experiments utilizing diﬀerent animals are shown. For both panels, values of activated moDC were compared to the corresponding immature moDC control (moDC), using a Kruskal-
Wallis test followed by Dunn’s multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05.
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low virulent NH/P68 and the avirulent BA71V. The latter is highly
attenuated being unable to infect swine and confer protection against
homologous BA71 challenge (Monteagudo et al., 2017). Instead, in-
oculation of pigs with the low virulence NH/P68 can confer protection
to challenge with the highly virulent ASFV/L60 isolate and thus is
considered a model to characterise mechanisms of protective immunity
to ASFV (Leitão et al., 2001).
We ﬁrst focused on determining both the susceptibility of immature
and IFN-α/TNF-α-matured moDC to ASFV infection and the ability of
ASFV BA71V, NH/P68 and 22653/14 to replicate in these cells. We
used an MOI of 1 to analyse moDC susceptibility to infection, whereas
we opted for a lower MOI to study ASFV replication and production of
infectious virus in these cells. Using a MOI of 1 we observed a high
percentage of dead moDC 40 h pi with the attenuated BA71V (data not
shown), so we opted for a lower MOI (0.01) to perform a kinetic ana-
lysis of the three ASFV strains in mature and immature moDC. All
Fig. 4. Growth kinetics of ASFV strains in immature and mature moDC. Immature moDC and moDC matured with IFN-α and/or TNF-α were infected with ASFV BA71V or NH/P68 or
22653/14, using an MOI of 0.01. At 0, 24, 48, 72 h pi duplicate samples were collected: virallevels in culture supernatants were assessed by both quantitative PCR and titration. The mean
data ± SD from three independent experiments utilizing diﬀerent animals are shown. At each time-point values of activated moDC were compared to the corresponding un-activated
control (moDC), using a Kruskal-Wallis test followed by Dunn’s multiple comparison test.
Fig. 5. Eﬀect of ASFV on the expression of functional surface markers by moDC. Immature moDC (white) and IFN-α/TNF-α matured moDC (black) were infected with BA71V or NH/P68
or 22653/14 strains, using an MOI 1, alongside mock-infected controls. 20 h pi, expression of surface markers (MHC I, MHC II DR, CD80/86, CD16) and p72 were assessed by ﬂow
cytometry. The mean data ± SD from three independent experiments utilizing diﬀerent animals are shown. For each marker, the mean ﬂuorescence intensity (MFI) of ASFV-infected or
bystander moDC were compared to the corresponding control (‘mock Vero’ for BA71V and ‘mock macro’ for NHP/68 and 22653/14), using a Mann-Whitney test or a Kruskal-Wallis test
followed by Dunn’s multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05.
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strains infected immature moDC, but activation with IFN-α but not
TNF-α alone resulted in an increased resistance to the attenuated
strains, with NH/P68 showing a reduced sensitivity compared to the
avirulent BA71V. A similar phenomenon has been observed in porcine
alveolar macrophages, where pre-treatment with IFN-α reduced re-
plication of attenuated but not virulent ASFV strains, which was at-
tributed to gene deletions in the region containing 360/530 multi-gene
families (Golding et al., 2016). We observed that diﬀerences were
mainly in the levels of late (p72) rather than early (p30) protein ex-
pression, which suggests that IFN-α inhibits ASFV infection progression.
These results are in accordance with a recent study, were sensitivity of
BA71V to type I IFN was described in Vero cells (Muñoz-Moreno et al.,
2016). Researchers observed that type I IFN treatment induced ex-
pression of interferon-induced trans-membrane (IFITM) proteins 1, 2, 3,
and over-expression of these antiviral factors caused a reduction in the
levels of both viral proteins p30 and p72 after BA71V infection, but the
latter in a more marked way (Muñoz-Moreno et al., 2016). Pre-treat-
ment of moDC with TNF-α/IFN-α enhanced susceptibility to infection
of virulent isolates, independently on their genotype, and our results
suggest that this eﬀect is mainly related to TNF-α. Although TNF-α is
known as a prototype pro-inﬂammatory cytokine which has a key role
in activation of the immune system to ﬁght viral infection, sometimes it
can instead favour viral replication. In a study on human cytomegalo-
virus (CMV) it was reported that addition of TNF-α promoted virus
production in infected macrophages (Soderberg-Naucler et al., 1997)
and a recent paper on spring viremia of carp virus (SVCV) described
that this cytokine can impair viral clearance by inhibition of the host
autophagic response (Espin-Palazon et al., 2016). It can be speculated
that also in porcine moDC TNF-α activation might result in the in-
hibition of autophagy, aﬀecting the elimination of ASFV intracellular
particles. Further experiments, especially in vivo studies, should in-
vestigate the eﬀect of anti-TNF-α therapy during ASFV infection.
Modulation of the expression of MHC class I and II and of the
costimulatory molecules CD80/86 may aﬀect antigen-presentation and
development of protective adaptive immune responses. Infection with
attenuated (BA71V and NH/P68) but not virulent 22653/14 resulted in
down-regulation of MHC class I on infected moDC. Similar results were
observed also in monocyte-derived macrophages (Franzoni et al., 2017)
and in vivo this down-regulation might result in NK cell activation
(Lanier, 2005). NK cell activation may play a role in protection against
ASFV and a previous study reported a correlation between NK activa-
tion and protection following NH/P68 inoculation (Leitão et al., 2001).
Another study also described that NH/P68 but not virulent Lisbon 60
isolate is able to stimulate NK cell activity in vitro (Martins and Leitáo,
1994) and this eﬀect could be related to down-regulation of MHC I on
infected myeloid cells. The discrimination between p72− and p72+
cells revealed that ASFV-infected mature moDC showed increased ex-
pression of MHC II DR compared to non-infected cells and this applied
to all the strains tested. Increased expression of MHC class II should
enhance interaction with and stimulation of T lymphocytes
(McCullough and Summerﬁeld, 2009), but ASFV might have developed
another mechanism, such as CD80/86 down-regulation, to impair the
activation of naïve T cells. As described in macrophages (Franzoni
et al., 2017), ASFV down-regulated expression of the low aﬃnity Fc
receptor CD16 also on moDC and this eﬀect has not been lost during
BA71V or NH/P68 attenuation. CD16 down-regulation might impair DC
function, reducing their ability to recognise opsonized virions.
Finally, we characterised the cytokine responses of porcine moDC to
ASFV infection. Compared to highly virulent strains, infection of mac-
rophages with attenuated ASFV strains results in enhanced expression
and/or production of several key regulatory cytokines (IFN-α, IFN-β,
TNF-α, IL-1β, IL-12, IL-18) (Gil et al., 2008, Reis et al., 2016, Franzoni
et al., 2017). We hypothesised that diﬀerences may also exist between
moDC cytokine responses to ASFV strains varying in virulence, with
possible implication in the acquisition of a protective immune response
against ASFV. It was reported that NH/P68 induced higher production
of TNF-α and IL-12p40 from infected macrophages than the virulent
L60 (Gil et al., 2008). In this study no release of TNF-α and IL-12 in
response to ASFV infection was observed. Diﬀerences might be linked
to the diﬀerent myeloid cells analysed or because IL-12p40 is also a
subunit of IL-23 (Duque and Descoteaux, 2014). In a recent work it was
reported that infection of macrophages with attenuated ASFV strains
resulted in high levels of IFN-β mRNA compared to the virulent Benin
(Reis et al., 2016), but we could not detect this cytokine in the super-
natants of infected moDC, regardless of the virulence of the strains
tested. This might be due to the diﬀerent myeloid cells analysed (moDC
instead of alveolar macrophages), or maybe post-transcriptional me-
chanisms inhibit IFN-β synthesis after mRNA production. In our pre-
vious work we reported a higher release of IL-1α, IL-1β and IL-18 from
classically activated macrophages following infection with BA71V
Fig. 6. IL-1α release by moDC in response to ASFV infection. Immature moDC and IFN-α/TNF-αmatured moDC (moDC+ IFN-α/TNF-α) were infected with BA71V or NH/P68 or 22653/
14 strains, using an MOI 1, alongside mock-infected controls. 20 h pi the amount of IL-1α in culture supernatants was evaluated. The mean data ± SD from three independent
experiments utilizing diﬀerent animals are shown. Values of ASFV-infected moDC were compared to the corresponding control (‘mock Vero’ for BA71V and ‘mock macro’ for NHP/68 and
22653/14), using a Mann-Whitney test or a Kruskal-Wallis test followed by Dunn’s multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05.
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compared with 22653/14 (Franzoni et al., 2017). Also in this study a
slight but statistically signiﬁcant increase in the release of IL-1α was
observed in response to BA71V, but not to NH/P68 or 22653/14 strains.
Surprisingly no release of the eight other cytokines tested was observed,
regardless of the tested strain. ASFV might have developed strategies to
inhibit transcriptional and post-transcriptional synthesis of these key
immunomodulatory proteins, thereby supporting covert replication in
these inﬂammatory DC.
5. Conclusion
Our analyses have shown that ASFV eﬃciently replicates in moDC,
resulting in modulation of important functional molecules and perhaps
most signiﬁcantly preventing the elicitation of a cytokine response.
Diﬀerences between ASFV strains of diverse virulence were observed:
attenuated strains were sensitive to IFN-α and infection with BA71V
and NH/P68, but not 22653/14, resulted in downregulated expression
of MHC class I on infected moDC, which in vivo might result in acti-
vation of protective immune responses. Collectively these data suggest
that ASFV may exploit inﬂammatory moDC to aid its modulation/
evasion of the host cellular immune response.
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